Avanos Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Avanos Medical
AVNS Stock  USD 14.63  0.02  0.14%   
Avanos Medical financial statements provide useful quarterly and yearly information to potential Avanos Medical investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Avanos Medical financial statements helps investors assess Avanos Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Avanos Medical's valuation are summarized below:
Gross Profit
381.3 M
Profit Margin
(0.57)
Market Capitalization
672.1 M
Enterprise Value Revenue
1.058
Revenue
687.8 M
There are over one hundred nineteen available fundamental signals for Avanos Medical, which can be analyzed over time and compared to other ratios. All traders should validate Avanos Medical's prevailing fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction. Enterprise Value is likely to gain to about 2.3 B in 2025, whereas Market Cap is likely to drop slightly above 1.4 B in 2025.

Avanos Medical Total Revenue

883.55 Million

Check Avanos Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Avanos Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 42.5 M, Interest Expense of 15.9 M or Selling General Administrative of 284 M, as well as many indicators such as Price To Sales Ratio of 1.45, Dividend Yield of 0.26 or PTB Ratio of 1.42. Avanos financial statements analysis is a perfect complement when working with Avanos Medical Valuation or Volatility modules.
  
Check out the analysis of Avanos Medical Correlation against competitors.
For more information on how to buy Avanos Stock please use our How to Invest in Avanos Medical guide.

Avanos Medical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding51.7 M46 M47.2 M
Slightly volatile
Short and Long Term Debt Total254.2 M170.2 M283.5 M
Very volatile
Property Plant And Equipment Net178.1 M144.8 M232.8 M
Slightly volatile
Non Current Assets Total1.1 B760.8 M1.4 B
Slightly volatile
Non Currrent Assets Other13 M23.2 M10.9 M
Slightly volatile
Cash And Short Term Investments156.3 M107.7 M131.2 M
Slightly volatile
Liabilities And Stockholders Equity1.6 B1.2 B2 B
Slightly volatile
Non Current Liabilities Total276.1 M159.8 M312.6 M
Very volatile
Property Plant And Equipment Gross194.2 M283.5 M250.1 M
Slightly volatile
Long Term Debt Total273 M203.7 M395.2 M
Slightly volatile
Capital Surpluse1.7 B1.9 B1.6 B
Slightly volatile
Non Current Liabilities Other190 K200 K28.9 M
Pretty Stable
Deferred Long Term Asset Charges11.9 M13.4 M14.6 M
Slightly volatile
Net Invested Capital1.2 B963.2 M1.6 B
Slightly volatile
Net Working Capital292 M227.5 M538 M
Slightly volatile
Capital Stock400 K450 K490.6 K
Slightly volatile
Capital Lease Obligations43.7 M35.5 M66.7 M
Slightly volatile

Avanos Medical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization42.5 M45.5 M52.4 M
Slightly volatile
Interest Expense15.9 M12.2 M13.6 M
Slightly volatile
Selling General Administrative284 M318.5 M350.3 M
Slightly volatile
Total Revenue883.6 M687.8 M1.1 B
Slightly volatile
Gross Profit372.7 M381.3 M467.9 M
Slightly volatile
Other Operating Expenses855.6 M1.1 B1.1 B
Slightly volatile
Research Development27.3 M26.2 M33.5 M
Slightly volatile
Cost Of Revenue510.9 M306.5 M657.5 M
Slightly volatile
Total Operating Expenses474.1 M777.5 M430.5 M
Slightly volatile
Non Operating Income Net Other2.1 M1.1 M2.5 M
Pretty Stable
Interest Income4.9 M5.1 M14.4 M
Slightly volatile
Non Recurring379.2 M426.6 M465.1 M
Slightly volatile
Reconciled Depreciation35 M45.5 M50.1 M
Slightly volatile
Selling And Marketing Expenses265.6 M298.8 M325.8 M
Slightly volatile

Avanos Medical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation12.2 M13.8 M10.6 M
Slightly volatile
Begin Period Cash Flow140.9 M87.7 M123 M
Slightly volatile
Depreciation42.5 M45.5 M52.4 M
Slightly volatile
Capital Expenditures31.2 M16 M38.5 M
Slightly volatile
End Period Cash Flow146.7 M107.7 M127.1 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.451.06471.7424
Pretty Stable
Dividend Yield0.260.290.3156
Slightly volatile
PTB Ratio1.420.88391.2512
Pretty Stable
Days Sales Outstanding54.6370.47463.8775
Slightly volatile
Book Value Per Share31.4818.010930.7464
Slightly volatile
Stock Based Compensation To Revenue0.01030.02010.012
Slightly volatile
Capex To Depreciation0.370.39120.7216
Slightly volatile
PB Ratio1.420.88391.2512
Pretty Stable
EV To Sales1.621.15561.8881
Slightly volatile
Inventory Turnover3.072.20822.9034
Slightly volatile
Days Of Inventory On Hand114165135
Slightly volatile
Payables Turnover6.255.64466.3301
Slightly volatile
Sales General And Administrative To Revenue0.240.470.3731
Slightly volatile
Research And Ddevelopement To Revenue0.02950.03810.0353
Slightly volatile
Capex To Revenue0.04220.02590.0378
Very volatile
Cash Per Share2.422.34132.7377
Pretty Stable
Payout Ratio20.0722.5824.6213
Slightly volatile
Days Payables Outstanding70.0964.663979.8785
Pretty Stable
Intangibles To Total Assets0.620.4920.5756
Pretty Stable
Current Ratio1.882.37132.2368
Slightly volatile
Receivables Turnover6.515.17926.3629
Slightly volatile
Shareholders Equity Per Share31.4818.010930.7464
Slightly volatile
Debt To Equity0.290.20540.2356
Pretty Stable
Capex Per Share0.370.3870.8064
Slightly volatile
Revenue Per Share25.9914.952224.5292
Slightly volatile
Interest Debt Per Share7.833.96526.4789
Pretty Stable
Debt To Assets0.130.14750.145
Pretty Stable
Graham Number34.4429.730.8496
Slightly volatile
Operating Cycle168236199
Slightly volatile
Price Book Value Ratio1.420.88391.2512
Pretty Stable
Days Of Payables Outstanding70.0964.663979.8785
Pretty Stable
Dividend Payout Ratio20.0722.5824.6213
Slightly volatile
Company Equity Multiplier1.631.39311.4609
Pretty Stable
Long Term Debt To Capitalization0.230.15320.2303
Slightly volatile
Total Debt To Capitalization0.210.17040.1747
Pretty Stable
Debt Equity Ratio0.290.20540.2356
Pretty Stable
Quick Ratio1.241.53471.4425
Slightly volatile
Cash Ratio0.470.64920.5255
Slightly volatile
Cash Conversion Cycle98.1171119
Slightly volatile
Days Of Inventory Outstanding114165135
Slightly volatile
Days Of Sales Outstanding54.6370.47463.8775
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.110.82321.3333
Pretty Stable
Price To Book Ratio1.420.88391.2512
Pretty Stable
Fixed Asset Turnover5.174.754.7905
Slightly volatile
Debt Ratio0.130.14750.145
Pretty Stable
Price Sales Ratio1.451.06471.7424
Pretty Stable
Asset Turnover0.580.59590.5522
Slightly volatile
Gross Profit Margin0.370.55440.4516
Slightly volatile
Price Fair Value1.420.88391.2512
Pretty Stable

Avanos Medical Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.4 B1.4 B1.6 B
Pretty Stable
Enterprise Value2.3 B2 B2 B
Pretty Stable

Avanos Fundamental Market Drivers

Cash And Short Term Investments107.7 M

Avanos Upcoming Events

20th of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Avanos Medical Financial Statements

Avanos Medical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Avanos Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Avanos Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Avanos Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue-4.5 M-4.3 M
Total Revenue687.8 M883.6 M
Cost Of Revenue306.5 M510.9 M
Stock Based Compensation To Revenue 0.02  0.01 
Sales General And Administrative To Revenue 0.47  0.24 
Research And Ddevelopement To Revenue 0.04  0.03 
Capex To Revenue 0.03  0.04 
Revenue Per Share 14.95  25.99 
Ebit Per Revenue(0.58)(0.55)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Avanos Stock Analysis

When running Avanos Medical's price analysis, check to measure Avanos Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avanos Medical is operating at the current time. Most of Avanos Medical's value examination focuses on studying past and present price action to predict the probability of Avanos Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avanos Medical's price. Additionally, you may evaluate how the addition of Avanos Medical to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY